跳至主要内容
临床试验/KCT0001498
KCT0001498已完成未知

The effects of valsartan on oxidative stress in type 2 diabetic patients with hypertension

Ajou University Hospital0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
30(Year) 至 80(Year)(—)
性别
All

入选标准

  • Type 2 DM patients
  • systolic BP (SBP) 135 – 160 mmHg and/or diastolic BP (DBP) 85 – 100 mmHg,
  • 30 - 80 years of age,
  • not taking antihypertensive drugs within 2 weeks prior to screening date
  • HbA1c =9.0%.

排除标准

  • secondary hypertension, impaired hepatic function (defined by serum levels of either ALT or AST >2.5 times the upper limit of normal), renal impairment (serum creatinine >2.0 mg/dL)), or any other clinically relevant serious disease, including malignancy, serious infection, heart failure, myocardial infarction or stroke within 6 months prior to the screening date, or patients who were pregnant, breast-feeding, or planning to bear a child, or whose low-density lipoprotein cholesterol (LDL-C) >160 mg/dL

研究者

发起方
Ajou University Hospital

相似试验